trastuzumab,tucatinib,temsirolimus,talazoparib,atezolizumab,abemaciclib,ipilimumab,palbociclib,sunitinib,pertuzumab,olaparib,vemurafenib,entrectinib,regorafenib,cobimetinib,nivolumab,futibatinib,larotrectinib,pembrolizumab
pfizer,bayer,roche,eli lilly,merck,otsuka,astrazeneca,bms,seagen
['tapur']
sounds a lot like #tapur, but we wrote the protocol 8 years ago! time for others to catch up!! 
I am a medical oncologist and the Principal Investigator of the American Society of Clinical Oncology TAPUR study. Tweets are my own.